Price movement over the last 24 hours
ARK Innovation ETF vs Progressive Corp — how do they compare? ARK Innovation ETF trades at $79.8, while Progressive Corp trades at $231.86 (market cap $134.33B). The key difference: Progressive Corp pays a 6.02% dividend while ARK Innovation ETF pays none, and Progressive Corp is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.
| ARKK | PGR | |
|---|---|---|
52-Week High | $92.50 | $252.68 |
52-Week Low | $63.52 | $190.40 |
Market Cap | — | $134.33B |
Sector | — | Financials |
Enterprise Value | — | $142.55B |
Dividend Yield | — | 6.02% |
Signals from Pluang's Aura AI — not financial advice
ARK Innovation ETF (ARKK) trades at $80.25, down 1.58% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The ETF has gained about 2% year-to-date through late June, sitting near its pivot point of $81. Recent news highlights Cathie Wood's continued stock purchases during pullbacks while the fund faces criticism for its 0.75% expense ratio and underperformance relative to broader tech markets.
The outlook remains mixed with strong technical momentum but fundamental concerns about fees and concentrated exposure to volatile innovation stocks. Key risks include Tesla's 10% weighting creating single-stock vulnerability and the fund's history of 37.88% losses over five years despite recent investor interest resurgence.
Progressive (PGR) trades at $230.72, up 0.52% on the day, with a bullish technical outlook indicated by moving averages and strong support at $228. The stock shows robust fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income surging to $11.3B. Recent earnings beats and a 36% jump in May 2026 net income highlight operational strength. The company maintains a solid net income margin of 12.93% and an impressive ROE of 37.9%.
The outlook for PGR is positive, supported by consistent earnings outperformance and analyst consensus pointing to upside with a $239.75 price target. Key risks include competitive pressures in the insurance sector and potential macroeconomic headwinds affecting consumer spending. Institutional sentiment is mixed but leans bullish, with 39% of analysts rating it a buy. The stock presents a compelling opportunity for growth investors seeking exposure to a financially healthy insurer.
Trailing returns across standard periods
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →